Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease.

Volume: 132, Pages: 275 - 294
Published: Jan 1, 2017
Abstract
Among the nonmotor symptoms in Parkinson's disease (PD), cognitive impairment is one of the most common and devastating. Over recent years, mild cognitive impairment (MCI) has become a recognized feature of PD (PD-MCI). The underlying mechanisms which influence onset, rate of decline, and conversion to dementia (PDD) are largely unknown. Adding to this uncertainty is the heterogeneity of cognitive domains affected. Currently there are no...
Paper Details
Title
Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease.
Published Date
Jan 1, 2017
Volume
132
Pages
275 - 294
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.